|
|
| (11) | Number of the document | C 1047694 |
| (68) | Number of the document | 1047694 |
| (21) | Application number for Supplementary Protection Certificate | PA 2008 012 |
| (22) | Date of filing the application | 2008-10-02 |
| (41) | Date of publication of the application | 2008-11-25 |
| Date of publication of SPC | 2009-05-25 | |
| (24) | Date of coming into effect of SPC | 2019-01-09 |
| (71) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue,, Greenford, Middlesex UB6 0NN,
GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/07/440/001, 2008-06-10 EU/1/07/440/002, 2008-06-10 |
| (94) | 2023-06-12 |
| (95) | Lapatinibum ditosylatum monohydricum |
| Payment date | Validity (years) | Amount | |
| 2023-01-02 | 347.00 EUR |
| SPC expired |